On cerebrotoxicity of antihypertensive therapy and risk factor cosmetics
- 28 December 2020
- journal article
- editorial
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 42 (7) , 758-760
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Midlife blood pressure is associated with the severity of white matter hyperintensities: analysis of the UK Biobank cohort studyEuropean Heart Journal, 2020
- Effects of Candesartan vs Lisinopril on Neurocognitive Function in Older Adults With Executive Mild Cognitive ImpairmentJAMA Network Open, 2020
- Blood Pressure and Risks of Cognitive Impairment and DementiaHypertension, 2020
- Cumulative Blood Pressure Exposure During Young Adulthood and Mobility and Cognitive Function in MidlifeCirculation, 2020
- NICE hypertension guidelines: a pragmatic compromiseThe Lancet, 2019
- A Randomized Trial of Intensive versus Standard Blood-Pressure ControlNew England Journal of Medicine, 2015
- Temporal Changes in Periprocedural Events in the Carotid Revascularization Endarterectomy Versus Stenting TrialStroke, 2015
- Systolic pressure is all that mattersThe Lancet, 2008
- Abandoning diastoleBMJ, 1999
- Risks of Correcting the Risks of Coronary Disease and Stroke with DrugsNew England Journal of Medicine, 1982